"10.1371_journal.pone.0073906","plos one","2013-09-12T00:00:00Z","Silvia Schiarea; Lolita Arnoldi; Roberto Fanelli; Eric De Combarieu; Chiara Chiabrando","Department of Environmental Health Sciences, IRCCS - Istituto di Ricerche Farmacologiche “Mario Negri”, Milano, Italy; Research and Development Laboratories, INDENA S.p.A., Settala, Milan, Italy","Conceived and designed the experiments: CC SS. Performed the experiments: SS. Analyzed the data: CC SS. Contributed reagents/materials/analysis tools: LA EDC. Wrote the manuscript: CC SS. Provided conceptual advice throughout the study: RF.","Two authors (LA and EDC) are employed by the funder, INDENA S. p. A.  INDENA S. p. A has a patent on the use of lupin conglutin, which is however completely unrelated to the content of this study. Patent title: The use of lupin conglutin for the treatment of type II diabetes Inventors: Morazzoni P., Duranti M. Priority: 11/02/2003 IT MI2003A 000237 Application: WO 2004/071521 (CA, CN, KR, JP, IN, IL, NO, PL, SG, US), HK 061060134
Granted: SG 114893, EP 1605957, RU 2339393, AU 2004212297.  This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Silvia Schiarea","SS",5,TRUE,2,1,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
